Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Yanaba

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Archives of Dermatological Research|October 12, 2012
Increased production of soluble inducible costimulator in patients with diffuse cutaneous systemic sclerosisKoichi Yanaba, Yoshihide Asano, Shinji Noda, et al.
Archives of Dermatological Research|December 3, 2013
Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosisYohei Ichimura, Yoshihide Asano, Kaname Akamata, et al.
Clinical Rheumatology|September 18, 2012
Increased circulating fibrinogen-like protein 2 in patients with systemic sclerosisKoichi Yanaba, Yoshihide Asano, Shinji Noda, et al.
Rheumatology (Oxford, England)|January 5, 2013
Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosisShinji Noda, Yoshihide Asano, Takehiro Takahashi, et al.
Archives of Dermatological Research|December 13, 2012
Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosisShinji Noda, Yoshihide Asano, Naohiko Aozasa, et al.
European Journal of Dermatology : EJD|February 26, 2014
Serum levels of mannose-binding lectin in systemic sclerosis: a possible contribution to the initiation of skin sclerosis in the diffuse cutaneous subtypeKaname Akamata, Yoshihide Asano, Naohiko Aozasa, et al.
Rheumatology International|October 22, 2013
Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosisYuri Masui, Yoshihide Asano, Kaname Akamata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2010
Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma modelAyumi Yoshizaki, Koichi Yanaba, Yohei Iwata, et al.
Rheumatology (Oxford, England)|February 28, 2013
A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune responseYuri Masui, Yoshihide Asano, Sayaka Shibata, et al.
The Journal of Dermatology|October 6, 2018
Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational studyHayakazu Sumida, Yoshihide Asano, Zenshiro Tamaki, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Archives of Dermatological Research|October 12, 2012
Increased production of soluble inducible costimulator in patients with diffuse cutaneous systemic sclerosisKoichi Yanaba, Yoshihide Asano, Shinji Noda, et al.
Archives of Dermatological Research|December 3, 2013
Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosisYohei Ichimura, Yoshihide Asano, Kaname Akamata, et al.
Clinical Rheumatology|September 18, 2012
Increased circulating fibrinogen-like protein 2 in patients with systemic sclerosisKoichi Yanaba, Yoshihide Asano, Shinji Noda, et al.
Rheumatology (Oxford, England)|January 5, 2013
Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosisShinji Noda, Yoshihide Asano, Takehiro Takahashi, et al.
Archives of Dermatological Research|December 13, 2012
Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosisShinji Noda, Yoshihide Asano, Naohiko Aozasa, et al.
European Journal of Dermatology : EJD|February 26, 2014
Serum levels of mannose-binding lectin in systemic sclerosis: a possible contribution to the initiation of skin sclerosis in the diffuse cutaneous subtypeKaname Akamata, Yoshihide Asano, Naohiko Aozasa, et al.
Rheumatology International|October 22, 2013
Serum resistin levels: a possible correlation with pulmonary vascular involvement in patients with systemic sclerosisYuri Masui, Yoshihide Asano, Kaname Akamata, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2010
Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma modelAyumi Yoshizaki, Koichi Yanaba, Yohei Iwata, et al.
Rheumatology (Oxford, England)|February 28, 2013
A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune responseYuri Masui, Yoshihide Asano, Sayaka Shibata, et al.
The Journal of Dermatology|October 6, 2018
Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational studyHayakazu Sumida, Yoshihide Asano, Zenshiro Tamaki, et al.
Pageof 13